Stocks to Watch Today: Which Indian Shares Are in Focus?
About the October 21, 2026 Stock Watchlist
Watchlist for Wednesday, October 21, 2026, highlights corporate earnings, order wins, expansion plans, business partnerships and regulatory developments. The positive list includes Reliance Industries, Infosys, L&T Technology Services, ABB India, Piramal Finance, Bajaj Finance and other companies. The negative list includes Sobha, Waaree Renewable Technologies, Delta Corp, SML Mahindra and Schaeffler India.
This article organises the reported developments into positive business triggers, negative earnings signals and risks that investors should monitor. A positive headline does not guarantee a share-price increase, and a negative headline does not guarantee a decline.
Corporate news can influence share prices by changing expectations about revenue, profitability, future orders and business risks. However, the market reaction also depends on valuations, investor expectations, liquidity and broader market conditions. Traders should distinguish a company's underlying development from the price action that follows it.
Key Highlights: Stocks in Focus
🔹 Reliance Industries: Reported discussions involving US Secretary of State Marco Rubio and Venezuelan crude refining.
🔹 L&T Technology Services: Constant-currency revenue growth reportedly exceeded estimates.
🔹 Infosys: Expanded collaboration with Truist to establish a global capability centre in India.
🔹 ABB India: Reported 81% year-over-year growth in India orders, according to the supplied watchlist.
🔹 Piramal Finance and Bajaj Finance: Reported growth in profitability and assets under management or operating performance.
🔹 Waaree Renewable Technologies, Delta Corp and Sobha: Earnings or margin pressures feature among the negative developments.
🔹 Schaeffler India: A reported police-custody development involving its managing director and CEO puts the company in focus; the circumstances and legal status require careful interpretation.
The list is best treated as a research starting point rather than a ready-made buy or sell list. Investors should check the underlying company announcements and compare reported performance with market expectations before taking a position.
For a broader framework to assess index direction and market conditions, readers can visit the Nifty Tip page. Individual stock developments and index signals should still be analysed separately.
Positive Developments: Stocks to Monitor
1. Reliance Industries
Reliance Industries is in focus following reports that US Secretary of State Marco Rubio said Washington would discuss refining more Venezuelan crude with Reliance. The development highlights India's refining capabilities and the commercial importance of processing different crude grades.
Reliance's Jamnagar complex has sophisticated refining capabilities, but any additional Venezuelan crude activity would depend on commercial terms, crude availability, applicable sanctions and licensing conditions. Discussions do not establish a final contract or guaranteed earnings benefit.
What to monitor: Official company disclosures, confirmed crude volumes, refining margins and any formal regulatory or commercial developments.
2. L&T Technology Services
The watchlist reports that Q2 constant-currency revenue growth reached 2.7%, above an estimated range of 1%–1.2%. It also refers to an engineering and innovation-related measure accounting for 9.5% of revenue; that abbreviated detail should be checked against the company's original results disclosure before being interpreted.
For an engineering and technology services company, revenue growth can indicate demand for its services, but investors also need to assess operating margins, deal conversion, client spending and the outlook for future quarters.
What to monitor: Constant-currency growth, operating margins, new deals, client demand and management guidance.
3. Infosys
Infosys has expanded its collaboration with US financial-services company Truist to build a global capability centre in India. Such centres can support technology, operations and specialised business functions for large organisations.
The potential commercial significance depends on the scope of the engagement, the services involved, staffing requirements and the extent to which the partnership translates into revenue. A partnership announcement alone does not disclose the total contract value unless the company specifies it.
What to monitor: The scale of the centre, hiring and delivery plans, deal conversion and the company's wider revenue outlook.
4. ABB India
The supplied watchlist cites 81% year-over-year growth in ABB India's Q2 India orders and positive commentary from its global parent. Order growth can provide an indication of demand for industrial automation, electrification and related equipment.
However, orders are not the same as recognised revenue or profit. Their financial contribution depends on execution schedules, project mix, pricing, costs and conversion into sales.
What to monitor: Order inflows, order backlog, revenue conversion, operating margins and demand across industrial sectors.
5. Piramal Finance
The watchlist reports that Piramal Finance's Q2 profit increased 67% year over year and assets under management rose 24%. These figures suggest improved reported profitability alongside expansion in its lending and financial-services business.
For a lender, growth should be assessed alongside asset quality, credit costs, funding costs, loan growth and capital adequacy. Rapid expansion is more valuable when the company maintains underwriting discipline and sustainable profitability.
What to monitor: Profit growth, net interest income, loan mix, non-performing assets and credit costs.
6. Bajaj Finance
The supplied watchlist reports operating profit growth of 23% and assets under management growth of 26.5% year over year. These measures can indicate business expansion and stronger operating performance.
Investors should also examine funding costs, credit quality, customer acquisition expenses and the sustainability of growth. A lender can expand its asset base rapidly, but the quality and profitability of those assets remain essential.
What to monitor: Loan growth, credit costs, margins, asset quality and management commentary.
7. Tatva Chintan Pharma Chem
The watchlist reports an 83% increase in EBITDA and 76% revenue growth year over year. Such growth can attract attention, but investors should determine whether it reflects a low comparison base, improved utilisation, product mix, pricing or a sustained increase in demand.
What to monitor: Revenue quality, EBITDA margin, capacity utilisation, customer demand and the outlook for future quarters.
8. Venus Pipes & Tubes
Venus Pipes reportedly commenced pipe-spooling operations ahead of schedule and received a letter of intent for an order worth ₹185 crore. The combination of capacity or operational progress and a sizeable order can be relevant to future business activity.
A letter of intent is not necessarily equivalent to a final binding contract. Investors should verify its terms, delivery schedule, margin profile, payment conditions and the company's ability to execute the order profitably.
What to monitor: Final order confirmation, execution timelines, revenue recognition, working-capital requirements and margins.
9. UltraTech Cement
The watchlist says UltraTech has committed to an EBITDA target of ₹1,400 per tonne by the exit of Q4 FY28 and plans further organic expansion. The target provides a framework for assessing the company's operating efficiency ambitions.
Per-tonne EBITDA depends on cement prices, fuel and power costs, freight, capacity utilisation and the geographic mix of sales. A target should be evaluated against actual quarterly performance rather than assumed to be achieved.
What to monitor: EBITDA per tonne, capacity additions, input costs, demand and management's progress against its stated target.
10. Sun Pharma
The watchlist reports that UNLOXCYT received a Category 2A preferred designation under updated National Comprehensive Cancer Network guidelines for certain advanced skin-cancer patients who are not eligible for surgery or radiation.
Clinical guideline recognition may support awareness and consideration of a medicine in relevant treatment settings. Its financial impact depends on eligible patient numbers, market access, reimbursement, uptake and competition. The precise indication and wording should be checked against the original guideline and company announcement.
What to monitor: The scope of the recommendation, eligible patient population, commercial uptake and company disclosures.
11. Quality Power, Edelweiss, Ceigall, Orchid Pharma and Alembic Pharmaceuticals
Quality Power: The watchlist reports commencement of operations at a new global coil factory in Maharashtra, expanding manufacturing capacity. Investors should track utilisation, orders and revenue contribution.
Edelweiss: Its arm EAAA India reportedly filed a red herring prospectus for an IPO involving an offer for sale of ₹1,200 crore. An offer for sale involves existing shareholders selling shares; it does not automatically mean the company receives the full proceeds.
Ceigall India: An arm reportedly signed a transmission-services agreement with the Central Transmission Utility of India. The commercial significance depends on the agreement's scope, value, responsibilities and execution period.
Orchid Pharma: The board reportedly approved enabling a resolution to raise up to ₹600 crore through a QIP or other means. Approval to pursue fundraising is not the same as a completed issue. Investors should monitor the final method, size, pricing and dilution implications.
Alembic Pharmaceuticals: The company reportedly incorporated a subsidiary in Dubai to explore new business opportunities. Incorporation establishes a corporate entity but does not by itself establish material revenue or profitability.
Negative Developments: Risks to Monitor
| Company | Reported Development | What Investors Should Check |
|---|---|---|
| Sobha | EBITDA down 28%; margin flat at 7% year over year. | Sales, project mix, costs, cash flow and management outlook. |
| Waaree Renewable Technologies | Net profit down 30%; margin reportedly 15% versus 20%. | Execution costs, revenue growth, project mix and margin sustainability. |
| Delta Corp | Reported a net loss versus a prior-year profit; margin down 380 basis points. | Revenue trends, operating costs, regulatory developments and cash position. |
| SML Mahindra | EBITDA down 31%; margin 4.3% versus 7.6%. | Vehicle demand, product mix, input costs and operating efficiency. |
| Schaeffler India | Reported police custody of the MD and CEO in connection with a factory accident. | Official company statements, verified legal developments and operational impact. |
The figures in the negative list highlight areas that warrant scrutiny, but the reason behind a decline matters. Lower margins may reflect temporary input-cost pressure, weaker pricing or a structural problem. Investors should examine the full results and compare year-over-year figures with sequential performance before drawing conclusions.
The Schaeffler India item requires particular care. A report of police custody is a legal development, not proof of guilt. Investors should rely on official statements and verified reporting rather than speculation about the individual or the company's eventual liability.
SWOT Analysis: Positive Corporate Triggers
Strengths
• Earnings growth and improving operating performance at selected companies.
• New partnerships, manufacturing capacity and order-related developments.
• Strong order growth can support future revenue visibility.
Weaknesses
• Some reported developments are preliminary or lack full financial details.
• Revenue and order growth do not automatically translate into profit or cash flow.
• Expectations may already be reflected in market prices.
Investors should also consider the broader market backdrop. Interest rates, crude oil prices, currency movements, foreign investment flows and global risk sentiment can influence how stock-specific news is priced. Even companies reporting strong results can fall if expectations were higher or the wider market weakens.
SWOT Analysis: Earnings and Company-Specific Risks
Opportunities
• Margin recovery could improve earnings at companies facing temporary cost pressure.
• Order conversion and new facilities may support future growth.
• Stronger disclosures can help investors reassess business prospects.
Threats
• Persistent margin compression can weaken earnings quality.
• Execution delays, regulation and funding needs may affect expected returns.
• Legal or governance developments can create uncertainty and volatility.
How Traders Can Use a Stocks-to-Watch List
A watchlist is most useful when it identifies a catalyst and a way to test the market's reaction. It should not be treated as an automatic entry signal.
🔹 Check the opening move: A positive headline may produce a gap-up, but the price can reverse if buyers fail to sustain momentum.
🔹 Compare price and volume: Strong volume can support a breakout interpretation, but volume alone does not establish direction.
🔹 Mark important levels: Use the previous session's high and low, opening range, VWAP and relevant support or resistance.
🔹 Check the wider market: Sector strength, index direction and institutional flows can affect individual-stock moves.
🔹 Define risk in advance: Set an invalidation level and position size before entering. Avoid chasing a stock simply because it appears in a positive news list.
Valuation and Investment View
The October 21 watchlist includes companies with positive earnings, orders, partnerships and expansion developments, alongside companies reporting margin pressure, losses or legal uncertainty. These developments have different implications and should not be treated as one uniform market signal.
The positive list deserves further investigation for earnings quality, order conversion and sustainability. The negative list calls for examination of margin drivers, balance-sheet strength, execution risks and the possibility that the reported weakness is temporary or persistent.
Overall view: Use the list to prioritise research, not to make unverified buy or sell decisions. Confirm company disclosures, assess valuation and wait for price action to support a trading setup. A news headline does not guarantee the next move in a stock.
For broader Indian index education, visit the BankNifty Tip page. Index trades require their own analysis, even when individual stocks have major news.
Investor Takeaway
Derivative Pro & Nifty Expert Gulshan Khera, CFP®, observes that the October 21 watchlist highlights the importance of separating corporate progress from market expectations. Revenue growth, strong order inflows and new partnerships can support a company's outlook, while falling margins, losses and legal uncertainty can raise risks. The decisive factors are the quality of the underlying numbers, their impact on future cash flow and whether the market has already priced in the news.
For more financial-market education, visit Indian-Share-Tips.com. For enquiries, contact 9988877963.
Related Queries on Indian Stocks and Corporate Results
1. What does a stock being on a positive watchlist mean?
It means a reported development may attract investor attention. It is not a guarantee that the stock will rise or a recommendation to buy it.
2. Why can a company report strong growth and still see its share price fall?
The market may have expected even stronger results, valuations may be stretched, margins may disappoint or broader market conditions may weaken.
3. What is the difference between revenue growth and profit growth?
Revenue measures sales, while profit reflects what remains after relevant costs and expenses. Revenue can rise while profit falls if costs increase faster.
4. Why do investors track order inflows?
Orders can provide visibility into potential future business, but their value depends on execution, delivery schedules, payment terms and margins.
5. How should traders approach negative earnings news?
They should assess the cause of the weakness, compare results with expectations, review price action and define risk before entering a trade.
6. Does a corporate announcement guarantee a trading opportunity?
No. A stock may already have priced in the news, and price reactions can reverse. Traders should combine verified information with independent technical and risk analysis.
SEBI Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy or sell securities. Company announcements and market conditions can change. Verify corporate disclosures and consider your risk tolerance before making investment decisions. Consult a SEBI-registered investment adviser where appropriate.
